Approved Hospital Formulary
Pharmacy - Home (sharepoint.com) Contact Pharmacy
Show Therapeutic Classes
Legacy Hazardous Drugs Do Not Tube List
QR Code Add Formweb to your mobile device
Android iOS
Approved Hospital Formulary
Pharmacy - Home (sharepoint.com) Contact Pharmacy
Search results for:

upadacitinib

upadacitinib
Brand names: Rinvoq
Form Strength
SOLUTION, ORAL 1mg/mL (180mL bottle)
TABLET, EXTENDED RELEASE, ORAL 15 mg, 30 mg (doses of 45 mg may be made with a 15 mg tablet and a 30 mg tablet)
VIEW MORE Disease-Modifying Antirheumatic Drugs
CLASS
923600
Additional Information:

Inpatient: Formulary, Restricted

    • For treatment of patients with moderate-to-severe IBD with documentation of failure of systemic corticosteroid and one TNF-α inhibitor
    • Complete baseline labs (CBC, tuberculosis, hepatitis screening) and ensure up-to-date varicella/herpes zoster immunization.
    • Ensure prior authorization for outpatient continuation.
Last updated: Sep. 3, 2025
Rhazdrugs upadacitinib






This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.

Copyright © 2025 Rpharmy, LLC ­ All Rights Reserved